Cargando…
Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
Earlier studies with montelukast (M) and telmisartan (T) have revealed their potential antiviral properties against SARS-CoV-2 wild-type (WT) but have not assessed their efficacy against emerging Variants of Concern (VOCs) such as Omicron. Our research fills this gap by investigating these drugs’ im...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385313/ https://www.ncbi.nlm.nih.gov/pubmed/37514075 http://dx.doi.org/10.3390/pharmaceutics15071891 |